Bigul

Board Meeting To Be Held On 12.08.2017

Subject:- Advance notice of Meeting of Board of Directors of the Company and Intimation to adopt Standalone Financial Results Pursuant to the provisions of Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that the meeting of the Board of Directors of the Company will be held on Saturday, the 12th day of August, 2017 inter-alia to consider the following:...
03-08-2017
Bigul

Closure of Trading Window

It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations and Company's Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed from 1st August, 2017 to 14th August, 2017 (both days inclusive). This closure of the Trading Window has been occasioned by reason of the meeting of the Board of Directors of the Company, which is scheduled to be held on...
31-07-2017
Bigul

Shareholding for the Period Ended June 30, 2017

Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
18-07-2017
Bigul

Statement Of Investor Complaints For The Quarter Ended 30Th June, 2017

Pursuant to the provisions of Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of investor grievances for the quarter ended 30th June, 2017. No. of investor complaints pending at the beginning of quarter NIL No. of investor complaints received during the quarter NIL...
18-07-2017
Bigul

Poly Medicure wins patent battle against B. Braun over IV catheters

Domestic medical devices maker Poly Medicure has won a patent battle against German major B. Braun Melsungen on IV catheters. The European Patent Office has ruled in favour of Poly Medicure...
23-06-2017
Bigul

Updates

Intimation of Appointment of Chief Operating Officer (COO) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Neeraj Raghuvanshi has joined the Company as Chief Operating Officer (COO) from 2nd June, 2017. He has got over 15 years of rich experience working in Medical devices Industry at top positions. He holds a degree...
09-06-2017
Bigul

Reply Against Discrepancies In Financial Result Of The Company For The Quarter\ Year Ended March 2017

With reference to your e-mail dated 17th May, 2017 regarding the subject matter, Please find attached the Audited Financial Results (Standalone and Consolidated) of our Company in the format as per Schedule III to the Companies Act, 2013 and Declaration of impact of Un-modified Audit Qualifications (Standalone & Consolidated). Kindly take a note of the same for your further needful and oblige us.
19-05-2017
Bigul

Financial Results For 31St March, 2017

Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 10th May, 2017, at Crowne Plaza Hotels, Community Center, Okhla Phase-I, New Delhi - 110020, approved the following businesses: a)Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2017. b)Recommendation of Final Dividend of Rs. 0.50 (fifty...
10-05-2017
Bigul

Board recommends Final Dividend

Poly Medicure Ltd has informed BSE that the Board of Directors at their meeting held on May 10, 2017, inter alia, approved the following businesses:- Recommendation of Final Dividend of Rs. 0.50 (fifty paise) per Equity Shares of Rs. 5 each for the Financial Year 2016-17 subject to approval of shareholders.
10-05-2017
Bigul

Outcome of Board Meeting

Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 10th May, 2017, at Crowne Plaza Hotels, Community Center, Okhla Phase-I, New Delhi - 110020, approved the following businesses: a)Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2017. b)Recommendation of Final Dividend of Rs. 0.50 (fifty...
10-05-2017
Next Page
Close

Let's Open Free Demat Account